☰

Anuran Chatterjee

Affiliations: 
University of California, San Francisco, San Francisco, CA 
Area:
Vascular disease
Google:
"Anuran Chatterjee"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mottola G, Werlin E, Wu B, et al. (2019) Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. Prostaglandins & Other Lipid Mediators. 106401
Chatterjee A, Komshian S, Sansbury BE, et al. (2017) Biosynthesis of proresolving lipid mediators by vascular cells and tissues. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Mottola G, Chatterjee A, Wu B, et al. (2017) Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. Plos One. 12: e0174936
Wu B, Mottola G, Chatterjee A, et al. (2016) Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. Journal of Vascular Surgery
Akagi D, Chen M, Toy R, et al. (2015) Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 2504-13
Chatterjee A, Sharma A, Chen M, et al. (2014) The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells. Plos One. 9: e113480
Miyahara T, Runge S, Chatterjee A, et al. (2013) D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2220-32
Chatterjee A, Snead C, Yetik-Anacak G, et al. (2008) Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. American Journal of Physiology. Lung Cellular and Molecular Physiology. 294: L755-63
See more...